HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1).

Abstract
Glutamine-fructose-6-phosphate transaminase 1 (GFPT1) is the first enzyme of the hexosamine biosynthetic pathway. It transfers an amino group from glutamine to fructose-6-phosphate to yield glucosamine-6-phosphate, thus providing the precursor for uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) synthesis. UDP-GlcNAc is an essential substrate for all mammalian glycosylation biosynthetic pathways and N-glycan branching is especially sensitive to alterations in the concentration of this sugar nucleotide. It has been reported that GFPT1 mutations lead to a distinct sub-class of congenital myasthenic syndromes (CMS) termed "limb-girdle CMS with tubular aggregates". CMS are hereditary neuromuscular transmission disorders in which neuromuscular junctions are impaired. To investigate whether alterations in protein glycosylation at the neuromuscular junction might be involved in this impairment, we have employed mass spectrometric strategies to study the N-glycomes of myoblasts and myotubes derived from two healthy controls, three GFPT1 patients, and four patients with other muscular diseases, namely CMS caused by mutations in DOK7, myopathy caused by mutations in MTND5, limb girdle muscular dystrophy type 2A (LGMD2A), and Pompe disease. A comparison of the relative abundances of bi-, tri-, and tetra-antennary N-glycans in each of the cell preparations revealed that all samples exhibited broadly similar levels of branching. Moreover, although some differences were observed in the relative abundances of some of the N-glycan constituents, these variations were modest and were not confined to the GFPT1 samples. Therefore, GFPT1 mutations in CMS patients do not appear to compromise global N-glycosylation in muscle cells.
AuthorsQiushi Chen, Juliane S Müller, Poh-Choo Pang, Steve H Laval, Stuart M Haslam, Hanns Lochmüller, Anne Dell
JournalBiomolecules (Biomolecules) Vol. 5 Issue 4 Pg. 2758-81 (Oct 16 2015) ISSN: 2218-273X [Electronic] Switzerland
PMID26501342 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DOK7 protein, human
  • Mitochondrial Proteins
  • Muscle Proteins
  • MT-ND5 protein, human
  • GFPT1 protein, human
  • Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)
  • Electron Transport Complex I
Topics
  • Adolescent
  • Adult
  • Case-Control Studies
  • Cells, Cultured
  • Electron Transport Complex I (genetics)
  • Female
  • Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) (genetics)
  • Glycosylation
  • Humans
  • Male
  • Middle Aged
  • Mitochondrial Proteins (genetics)
  • Muscle Proteins (genetics)
  • Myasthenic Syndromes, Congenital (genetics, metabolism)
  • Myoblasts (metabolism)
  • Protein Processing, Post-Translational

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: